A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence

A Real-World Evidence Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults

This study will collect effectiveness and safety data on JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults based on real world data.

There will be 30 participants selected who undergo 3D imaging before and after JUVÉDERM VOLUX® treatment for digital analysis assessments. Up to 90 participants enrolled either prospectively prior to JUVÉDERM VOLUX® treatment or retrospectively after JUVÉDERM VOLUX® treatment.

Inclusion Criteria:

-Participant has chin retrusion seeking chin enhancement who have received or plan to receive VOLUX chin treatment in Hainan Boao Super Hospital.

Exclusion Criteria:

• History of hypersensitivity to lidocaine,HA, or Streptococcal protein
• History of tendency to develop hypertrophic scarring
• Untreated epilepsy or porphyria
• Current cutaneous inflammatory or infectious processes (eg, acne, herpes) in the treatment area
• Prior chin or jaw surgery, including cartilage grafts or implantation of any biomaterials
• Permanent filler, semi-permanent filler, or fat injected in the treatment area
• Temporary filler, other than VOLUX, injected in the treatment area within 12 months before enrollment
• Females who self-report current pregnancy or breastfeeding